| Serial Number | 97861964 |
| Word Mark | REVERE |
| Filing Date | Tuesday, March 28, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Wednesday, March 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations for the treatment oncological diseases and conditions, kidney diseases and conditions, inflammatory diseases and conditions and central nervous system diseases and conditions |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 20, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Revere Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Arlington, MA 02474 |
| Event Date | Event Description |
| Wednesday, March 13, 2024 | CORRESPONDENCE E-MAILED |
| Wednesday, March 13, 2024 | SUSPENSION LETTER WRITTEN |
| Wednesday, March 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, December 23, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, December 23, 2023 | NON-FINAL ACTION E-MAILED |
| Saturday, December 23, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, December 21, 2023 | ASSIGNED TO EXAMINER |
| Thursday, April 20, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 31, 2023 | NEW APPLICATION ENTERED |